Literature DB >> 2662210

Clinical and molecular studies in Duchenne muscular dystrophy.

A E Emery1.   

Abstract

X-linked DMD is a serious condition characterized by progressive muscle wasting and weakness and death ensues in the late teens or early twenties. There is considerable clinical variability even within families and some suggestions of genetic heterogeneity. Though skeletal muscle is primarily involved, other tissues are also affected including cardiac and smooth muscle. Other abnormalities include mental retardation, thymus hyperplasia and possibly certain endocrinological changes. The responsible locus is at Xp21 and the gene product is a very large protein (dystrophin) which is normally localised to muscle cell membranes. It is hypothesised that its absence in DMD may result in instability of the muscle cell membrane with resultant ingress of calcium, an increase in intracellular calcium, and cell death. An understanding of this pathway is important in devising an effective treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2662210

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  10 in total

1.  A muscle-specific enhancer within intron 1 of the human dystrophin gene is functionally dependent on single MEF-1/E box and MEF-2/AT-rich sequence motifs.

Authors:  H J Klamut; L O Bosnoyan-Collins; R G Worton; P N Ray
Journal:  Nucleic Acids Res       Date:  1997-04-15       Impact factor: 16.971

2.  Degenerative and regenerative features of myofibers differ among skeletal muscles in a murine model of muscular dystrophy.

Authors:  Teppei Ikeda; Osamu Ichii; Saori Otsuka-Kanazawa; Teppei Nakamura; Yaser Hosny Ali Elewa; Yasuhiro Kon
Journal:  J Muscle Res Cell Motil       Date:  2016-07-29       Impact factor: 2.698

3.  Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice.

Authors:  Y Torrente; J P Tremblay; F Pisati; M Belicchi; B Rossi; M Sironi; F Fortunato; M El Fahime; M G D'Angelo; N J Caron; G Constantin; D Paulin; G Scarlato; N Bresolin
Journal:  J Cell Biol       Date:  2001-01-22       Impact factor: 10.539

Review 4.  The role of oxidative stress in skeletal muscle injury and regeneration: focus on antioxidant enzymes.

Authors:  Magdalena Kozakowska; Katarzyna Pietraszek-Gremplewicz; Alicja Jozkowicz; Jozef Dulak
Journal:  J Muscle Res Cell Motil       Date:  2016-01-04       Impact factor: 2.698

5.  Mitochondrial Dysfunction Is an Early Consequence of Partial or Complete Dystrophin Loss in mdx Mice.

Authors:  Timothy M Moore; Amanda J Lin; Alexander R Strumwasser; Kevin Cory; Kate Whitney; Theodore Ho; Timothy Ho; Joseph L Lee; Daniel H Rucker; Christina Q Nguyen; Aidan Yackly; Sushil K Mahata; Jonathan Wanagat; Linsey Stiles; Lorraine P Turcotte; Rachelle H Crosbie; Zhenqi Zhou
Journal:  Front Physiol       Date:  2020-06-19       Impact factor: 4.566

6.  Quadriceps muscle strength in Duchenne muscular dystrophy and effect of corticosteroid treatment.

Authors:  Luciano Merlini; Ilaria Cecconi; Antonia Parmeggiani; Duccio Maria Cordelli; Ada Dormi
Journal:  Acta Myol       Date:  2020-12-01

7.  Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model.

Authors:  Yvan Torrente; Geoffrey Camirand; Federica Pisati; Marzia Belicchi; Barbara Rossi; Fabio Colombo; Mosthapha El Fahime; Nicolas J Caron; Andrew C Issekutz; Gabriela Constantin; Jacques P Tremblay; Nereo Bresolin
Journal:  J Cell Biol       Date:  2003-07-28       Impact factor: 10.539

8.  Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome.

Authors:  Julian L Griffin; Christine Des Rosiers
Journal:  Genome Med       Date:  2009-03-25       Impact factor: 11.117

9.  Exon deletion pattern in duchene muscular dystrophy in north west of iran.

Authors:  Mohammad Barzegar; Parinaz Habibi; Mortaza Bonyady; Vahideh Topchizadeh; Shadi Shiva
Journal:  Iran J Child Neurol       Date:  2015

10.  Bone Mineral Density and Bone Metabolism in Patients with Duchenne Muscular Dystrophy.

Authors:  Mohammad Barzegar; Elnaz Niknam; Parinaz Habibi; Shadi Shiva; Sanaz Tahmasebi
Journal:  Iran J Child Neurol       Date:  2018
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.